Learn more

LIPOTEC SA

Overview
  • Total Patents
    334
  • GoodIP Patent Rank
    97,467
  • Filing trend
    ⇧ 100.0%
About

LIPOTEC SA has a total of 334 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 1992. It filed its patents most often in EPO (European Patent Office), Spain and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are REGERON INC, INST EUROPEEN BIOLOG CELLULAIR and YU RUEY J.

Patent filings per year

Chart showing LIPOTEC SAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Alminana Domenech Nuria 90
#2 Cebrian Puche Juan 87
#3 Ferrer Montiel Antonio 73
#4 Van Den Nest Wim 57
#5 Carreno Serraima Cristina 57
#6 Delgado Gonzalez Raquel 57
#7 Garcia Anton Jose Maria 43
#8 Parente Duena Antonio 34
#9 Ferrer Montiel Antonio Vicente 31
#10 Passerini Elena 30

Latest patents

Publication Filing date Title
EP2976060A1 Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
EP2868308A1 Expolysaccharide for the treatment and/or care of skin, culture media and compositions thereof
CN104254339A Compounds for the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
EP2792684A1 Compounds useful in the treatment and/or care of the skin and their cosmetic or pharmaceutical compositions
EP2740484A1 Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions
BR112014010698A2 peptide, procedure for preparing a peptide, and cosmetic or pharmaceutical composition
CN104023737A Peptides which inhibit activated receptors and their use in cosmetic or pharmaceutical compositions
EP2649983A1 Compounds which inhibit neuronal exocytosis (II)
EP2649984A1 Compounds which inhibit neuronal exocytosis
EP2649985A1 Compounds which inhibit neuronal exocytosis (III)
KR20140043727A Peptides useful in the treatment and/or care of the skin and/or mucous membranes and their use in cosmetic or pharmaceutical compositions
WO2012130775A1 Pgc-1alpha-modulating peptides
ES2424294A1 Exopolysaccharide for the treatment and / or care of skin, mucous membranes, hair and / or nails
AU2011264125A1 Skin antiaging treatment
ES2390033A1 EXOPOLISACÁRIDO FOR THE TREATMENT AND / OR CARE OF SKIN, MUCOSAS, HAIR AND / OR NAILS.
ES2386177A1 Nanocapsules containing microemulsions
AU2010275688A1 Compounds which inhibit muscle contraction
AU2010237349A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions
ES2383271A1 Processing processing of fibers and / or textile materials
ES2384060A1 Lipid nanoparticles capsules.